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Background: Despite its common acceptance in clinical practice, the effective
benefits of normothermic systemic perfusion during coronary artery bypass opera-
tions are far from established.
Methods: A total of 113 patients undergoing primary isolated coronary artery bypass
were randomly assigned to normothermic (37°C) or hypothermic (26°C) systemic
perfusion. The clinical course of the patients was prospectively recorded, and
several inflammatory and fibrinolytic markers (C-reactive protein, fibrinogen, inter-
leukin 6, plasminogen activator inhibitor 1, prothrombin time, activated partial
thromboplastin time, platelets, and white blood cell counts) were determined before
surgical intervention; 24, 48, and 72 hours thereafter; and at hospital discharge.
Results: Postoperatively, 2 in-hospital deaths occurred in the normothermic series
and none in the hypothermic series. Four patients had a myocardial infarction, 1 had
respiratory insufficiency, 1 had to be reoperated on for graft malfunction, and none
had renal insufficiency in the hypothermic group versus 1 patient with each of these
complications in the normothermic series. Mean blood loss in the first 24 hours was
766  223 mL in the normothermic group and 740  220 mL in the hypothermic
group. None of these differences was statistically significant. Similarly, no signif-
icant difference in the postoperative level of any of the measured variables at any
time point was evident between the patients in the normothermic and hypothermic
groups.
Conclusion: Normothermic systemic perfusion does not influence the clinical course
or the extent of inflammatory and hemostatic activation in patients undergoing
primary isolated coronary artery bypass.
Although, in recent years, normothermic cardiopulmonary bypass(CPB) has often been adopted in common practice, its effectivebenefits are far from established. Theoretically, normothermicsystemic perfusion (NSP) should reduce the extent of activationof the inflammatory system and maintain a better cellular homeo-static function and thus minimize the post-CPB systemic syn-
drome.1 However, this theoretic assumption is, at present, supported by little
objective evidence.
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This prospective randomized investigation was con-
ceived to elucidate the effect of CPB temperature on the
postoperative activation of the hemostatic and inflammatory
systems in patients submitted to isolated coronary artery
bypass procedures by using both clinical and hematic in-
dexes.
Patients and Methods
Patient Population
On approval of the Ethics Committee of the Catholic University, a
prospective study on the effect of CPB temperature on postoper-
ative hemostatic and inflammatory activation in patients undergo-
ing coronary artery bypass grafting (CABG) was started in January
1998 (Fibrinolisi e Infiammazione nella Fase Acuta: FIFA study).
From this date on, all patients scheduled to undergo isolated
elective CABG at our center were screened. Rigorous exclusion
criteria were adopted to maximize homogeneity and comparability
between groups: Patients with associated cardiac or noncardiac
surgical procedures, age greater than 80 years, single-vessel dis-
ease, emergency or urgent revascularization, left ventricular ejec-
tion fraction of less than 0.30, carotid artery disease, previous
cerebrovascular accident, chronic dialysis, hepatic failure, respira-
tory or renal insufficiency, hemorrhagic conditions, active infec-
tion, and chronic anti-inflammatory therapy were all excluded
from the study. Only patients operated on between 8 and 10 AM
were considered to rule out possible confounding effects of circa-
dian variability. After enrollment, patients were randomly assigned
to be operated on with normothermic versus hypothermic CPB.
(We adopted a 1:1 randomization according to a computer-gener-
ated random series of numbers.)
All patients gave their consent to participate in the protocol.
Data collection ended in May 1999, and a total of 113 patients
were included.
Surgical Technique
After median sternotomy, CPB was instituted in standard fashion
by cannulating the right atrium and the ascending aorta. For
anticoagulation, an intravenous bolus of heparin (300 IU/kg) was
followed by boluses of 100 IU/kg to maintain activated clotting
times of longer than 400 seconds.
During CPB, the nasopharyngeal temperature was kept at 37°C
in the normothermic group (patients were actively rewarmed if
their nasopharyngeal temperature fell below 34°C) and at 26°C in
the hypothermic series. Myocardial protection was always accom-
plished by means of anterograde isothermic intermittent blood
cardioplegia.
The left internal thoracic artery was used to graft the left
anterior descending coronary artery, and other venous or arterial
conduits were used for the remaining target coronary vessels. At
the end of CPB, anticoagulation was reversed with protamine
sulfate (1-1.5 mg per 100 IU of heparin).
Samples and Assays
Blood samples were collected immediately before surgical inter-
vention; 24, 48, and 72 hours thereafter; and at hospital discharge.
The samples were collected in trisodium citrate (0.106 mol/L) and
centrifuged without delay at 3000g and 4°C for 20 minutes.
Plasma was stored at –80°C within 1 hour of sampling, and
cellular pellets were kept at –20°C.
The plasma concentrations of the following factors were meas-
ured in a core laboratory blinded to the patients’ status: C-reactive
protein (CRP) was measured by using the nephelometric method
(APS; Beckman, Palo Alto, Calif); plasma fibrinogen concentra-
tions were assayed by using the modified Clauss functional method
(Instrumentation Laboratory SpA, Milan, Italy); interleukin (IL) 6
levels were analyzed by using the IL-6 Human Biotrak Elisa
System (Amersham Pharmacia Biotech, Monza, Italy).
Plasminogen activator inhibitor 1 (PAI-1) antigen levels were
determined by means of double-antibody sandwich enzyme-linked
immunosorbent assay (Instrumentation Laboratory SpA). This
marker was chosen to assess the fibrinolytic capacity of plasma
because it rapidly, irreversibly, and specifically inhibits both tis-
sue-type and urokinase-type plasminogen activator.2
Measurement of prothrombin time (expressed as international
normalized ratio [INR]), activated partial thromboplastin time
TABLE 1. Patient’s preoperative characteristics in the entire group and in relation to the CPB temperature used at surgical
intervention
Overall
Normothermic
group
Hypothermic
group P value*
No. of patients 113 55 58 —
Male/female ratio 105/8 52/3 53/5 .51
Cardiac risk factors
Diabetes 23 13 10 .36
Smoking 45 19 26 .19
Dislipemia 30 19 11 .06
Hypertension 71 31 40 .20
Family history of CAD 34 18 16 .85
Previous MI 57 24 33 .08
Left main disease 11 7 4 .29
Heart failure 5 3 2 .63
Ejection fraction 0.50 29 15 14 .70
CAD, Coronary artery disease; MI, myocardial infarction; EF, ejection fraction.
* Between normothermic and hypothermic groups.
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(PTT), and platelet, white blood cell (WBC), neutrophil, lympho-
cyte, and monocyte counts was performed in the hospital labora-
tory and was used also for clinical purposes in the management of
patients after the intervention (see Appendix).
Statistical Analysis
The 2 or Fisher exact test was used to compare discrete variables.
Correlations were assessed by using the Pearson or Spearman
methods. Continuous variables (presented as means  SD) were
compared by means of parametric or nonparametric (Kruskal-
Wallis) analysis of variance. Repeated-measures multivariate anal-
ysis of variance (GLM procedure for SAS) was used to assess
changes in levels of the different parameters over time in the
overall population and according to the CPB temperature. Analy-
ses were carried out with the SAS statistical package.
Results
The preoperative features of the patients are shown in Table
1. Normothermic and hypothermic groups did not differ
significantly in age, sex, major coronary risk factors, previ-
ous myocardial infarction, history of congestive heart fail-
ure, and angiographic characteristics.
Operative Data
Operative results are given in Table 2. No significant dif-
ferences in CPB and aortic crossclamp times or number of
grafts per patient were noted between the normothermic and
hypothermic series.
Clinical Results
The postoperative course of the 113 patients is summarized
in Table 3. Two in-hospital deaths occurred in the normo-
TABLE 2. Operative data in the entire group and in relation to the CPB temperature used at surgical intervention
Overall
Normothermic
group
Hypothermic
group P value*
CPB time (min) 75 21 74.5 18.3 87.5 21.7 .12
Crossclamp time (min) 62 18 62.1 16.0 73.3 19.1 .71
Grafts/patient
2 22 11 11 .92
3 56 29 27 .87
4 30 13 17 .63
5 5 1 4 .39
* Between normothermic and hypothermic groups.
TABLE 3. Postoperative mortality and morbidity in the entire series and in relation to the CPB temperature used at surgical
intervention
Overall
Normothermic
group
Hypothermic
group P value*
Death 2 2 0 .14
Stroke 0 0 0 —
MI 5 1 4 .18
Sepsis 1 0 1 .32
Shock 1 0 1 .32
Renal insufficiency 1 1 0 .30
Respiratory insufficiency 2 1 1 .97
Ventilation 24 h 9 4 5 .79
Reoperation 2 1 1 .97
Postoperative bleeding (mL/24 h) 753 218 766 223 740 220 .53
Revision for bleeding 8 3 5 .51
Atrial fibrillation 24 11 13 .95
Need for blood transfusion 28 10 18 .11
Major complications 6 2 4 .44
Minor complications 37 15 22 .22
Hemorrhagic complications 31 12 19 .19
Any complication 38† 15 23 .16
Mean ICU stay (d) 2.0 2.7 1.6 0.9 2.1 3.3 .27
Mean postoperative stay (d) 6.1 3.2 5.6 1.4 6.3 3.9 .22
MI, Myocardial infarction.
*Between normothermic and hypothermic groups.
†Five patients had both major and minor complications.
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thermic series as a result of massive pulmonary embolism
(on the third postoperative day) and myocardial infarction
(8 days after the operation). Postoperatively, 5 patients
experienced myocardial infarction, 2 had respiratory insuf-
ficiency, 1 had renal insufficiency, 1 had a septic syndrome,
and 2 had to be reoperated on for clinical and instrumental
evidence of graft malfunction. Eight patients needed a sur-
gical revision of the hemostasis, and 28 needed at least one
postoperative blood transfusion. Overall, 38 patients expe-
rienced at least 1 postoperative complication (6 major and
37 minor), and 31 had hemorrhagic complications.
Mean stay in the intensive care unit (ICU) and in-hospi-
tal stay after the operation were 2.0  2.7 and 6.1  3.2
days, respectively.
No significant differences in mortality and type and
incidence of postoperative complications were found be-
tween patients operated on with normothermic CPB versus
those operated on with hypothermic CPB (Table 3). In the
hypothermic series postoperative myocardial infarction and
need for blood products occurred slightly more frequently
(leading to a greater incidence of minor and hemorrhagic
complications in this series), but these differences did not
reach statistical significance. Mean blood loss did not sig-
nificantly differ between the 2 subgroups.
Similarly, the mean stay in the ICU and in-hospital stay
after the operation were similar between the 2 groups (al-
though slightly superior among hypothermic patients).
Markers of Hemostatic and Inflammatory Activity
Both hemostatic and inflammatory markers changed signif-
icantly in the postoperative period: IL-6 and WBC, neutro-
phil, monocyte, and lymphocyte counts peaked in the first
hours after the operation. CRP levels peaked at 72 hours and
remained elevated at discharge, whereas platelet levels were
greatly reduced 48 hours after the operation and returned to
normal values at the time of discharge. Mean fibrinogen
Figure 1. Indexes of coagulation in the normothermic versus hypothermic series at the different sampling inter-
vals.
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concentrations declined slightly at 24 hours and then in-
creased steadily until discharge (acting as an acute-phase
protein), PTT showed only a trend toward prolongation at
24 hours, and INR values increased at 24 hours and returned
to normal values 48 hours after the operation. Both PAI
antigen and activity increased roughly 2-fold at 24 to 48
hours after the operation (acting as an acute-phase reactant)
and tended to almost normalize by the time of discharge.
No significant difference in the postoperative level of
any of the measured variables at any time point was evident
between the patients undergoing normothermic and hypo-
thermic CPB (Figures 1-4). The mean postoperative con-
centrations of fibrinogen, CRP, IL-6, and PAI-1, as well as
the platelet and WBC counts and the PTT and INR, were
similar between the 2 groups at all sampling intervals.
Discussion
Despite its wide acceptance in common practice, the effec-
tive clinical benefits of NSP are far from being established.
The majority of trials comparing normothermic and hypo-
thermic CPB have demonstrated the similarities of the 2
strategies in terms of gross clinical indexes (mortality, mor-
bidity, and length of postoperative stay), and no substantial
systemic benefit related to the use of NSP has to date been
definitely shown. In fact, the only advantages uniformly
reported in almost all investigations are the earlier resump-
tion of spontaneous cardiac activity (with consequent re-
duced need for electrical defibrillation and pacemaker use)
and reduced systemic vascular resistance,3,4 both findings
with limited clinical implications. Other differences (eg,
better preservation of pulmonary function and reduced
bleeding tendency) have inconsistently been described in
different series or detected only in studies with limited
statistical power.5
On the other hand, major concerns about the safety of
NSP (mainly with regard to central nervous system protec-
tion) have been expressed by several authors. Although the
early report of a greater incidence of stroke in patients
operated on with normothermic CPB has not been con-
firmed in successive studies,6,7 we recently showed how
normothermia is associated with a superior extension of
brain damage and a worse neurologic outcome in patients
who had an intraoperative stroke.8,9
The lack of major clinical benefits and the possibility of
deleterious effects suggests caution with regard to the wide-
spread adoption of NSP and warrants further investigation
into its limits and advantages.
One of the presumed theoretic benefits of normothermia
is a better maintenance of the cellular and humoral homeo-
static processes (less efficient in hypothermic conditions),
Figure 2. PAI-1 antigen and activity in the normothermic versus hypothermic series at the different sampling
intervals.
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with consequent reduction of the systemic reaction to CPB
and of CPB-induced multisystem organ damage. However,
this theoretic assumption (which constitutes one of the main
conceptual arguments in favor of NSP) has found only
partial confirmation on the basis of objective data.
Indeed, the major studies investigating the relationship
between extracorporeal circulation temperature and degree
of activation of the inflammatory system have reported
conflicting results, supporting in turn a proinflammatory10
or anti-inflammatory11,12 effect of NSP or the lack of major
differences.13
Similar contradictions exist among the various investi-
gations that have focused on postoperative indexes of acti-
vation of coagulation in patients operated on with hypother-
mic systemic perfusion versus NSP, with some series
detecting a more pronounced alteration of the coagulation
system after hypothermia14,15 and others describing no sig-
nificant differences between the 2 temperatures.16,17
However, it must be stressed that the great majority of
these studies were conducted on a limited number of pa-
tients and had a small number of sampling intervals and low
statistical power. Moreover, most of them were not prospec-
tive randomized investigations and lacked rigorous criteria
for the patients’ inclusion and surgical management. In
addition, the definition of both hypothermia and normother-
mia adopted by the different authors has been quite hetero-
geneous, thereby hindering an accurate comparison of the
results from the various groups.
In our series CPB temperatures did not significantly
affect in-hospital clinical results or laboratory evidence of
activation of the inflammatory and hemostatic systems in
patients undergoing primary isolated CABG. Mortality,
morbidity, number, and type of postoperative complica-
tions; bleeding tendency; and ICU and in-hospital stay were
comparable between the 2 groups (although a small ten-
dency toward a greater incidence of postoperative compli-
cations was registered in the hypothermic series). More
interestingly, no difference between hypothermic and nor-
mothermic CPB was found for any of the measured hematic
markers of activation of the inflammatory and hemostatic
system (CRP, IL-6, WBC and platelet counts, PAI-1, fibrin-
ogen, INR, and PTT) at any time point.
Although these laboratory data are in contrast with those
reported by most of the other trials on this subject, meth-
odological and statistical issues seem the most probable
explanation for this difference. In fact, in contrast with the
described limitations of the previous reports, our study
included a prospective randomized design, rigorous enroll-
ment criteria, and a uniform surgical protocol. Although the
absolute magnitude of our patient population is not wide,
and the possibility of a type II statistical error can not be
completely excluded, the high complexity and cost of sen-
Figure 3. CRP and IL-6 levels in the normothermic versus hypothermic series at the different sampling intervals.
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sible biochemical markers in patients undergoing cardiac
surgery obviously limit the enrollment of a larger cohort of
patients in this type of investigation, and in fact, our study
has a sample size far larger than those of all published series
on this issue.
These considerations provide strong arguments in favor
of the reliability of our observations and are very likely to
render the reasons for the discrepancies between our obser-
vations and those already published.
It is also noteworthy that those clinical trials on hypo-
thermic versus normothermic CPB with sufficient statistical
power and with a rigorous study design failed to demon-
strate any significant difference in the postoperative course
(including mortality, incidence, type of complications, and
length of ICU stay) and blood loss between patients oper-
ated on with warm or cold bypass.3,4 Even those clinical
studies that specifically investigated the difference in the
amount of postoperative blood loss between hypothermic
and normothermic perfusion could not demonstrate any
substantial reduction by using warm CPB.15,18-20
Figure 4. Platelet and white cell counts in the normothermic versus hypothermic series at the different sampling
intervals.
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Therefore, these sound clinical data seem to deny any
measurable advantage of normothermia with regard to post-
operative bleeding and provide a strong clinical correlate to
our observations.
On this basis, it seems reasonable to assume that, in
low-risk patients undergoing primary isolated CABG, NSP
does not reduce (or increase) the extent of postoperative
systemic inflammatory reaction or of activation of the he-
mostatic system. Although our study focused on highly
selected cases and cannot definitely rule out possible differ-
ences in patients with organ dysfunction or those undergo-
ing more complex cardiac operations, the almost identical
magnitude of the systemic reaction to hypothermic and
normothermic CPB (measured even using very sensible
indexes) renders the hypothesis that these eventual differ-
ences are of any clinical relevance at least unlikely. These
results, coupled with the reported concerns about neurologic
safety with NSP, raise new doubts about the effective clin-
ical advantages of normothermia in cardiac surgery and
indicate the need for further careful investigation on the real
pros and cons of normothermic CPB and on its specific
effects on every organ and system.
We thank Dr Augusto Di Castelnuovo for statistical analysis;
Drs Piergiorgio Bruno, Elisabetta Lapenna, and Filippo Santarelli
for sample collection; and Concetta Amore for laboratory evalu-
ations.
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Appendix
Definitions
For the purpose of this report, the following definitions were
used:
● Carotid disease: Monolateral or bilateral carotid steno-
sis of 70% or greater demonstrated by means of pre-
operative Doppler echocardiography and carotid an-
giography.
● Myocardial infarction: Diagnosed on the basis of echo-
cardiographic evidence of regional hypokinesia or dys-
kinesia, MB fraction of greater than 4% of the total
hematic level of creatine kinase concentration, and
appearance of new Q waves on the electrocardiogram.
● Renal insufficiency: Postoperative increase of the se-
rum creatinine level of 2 mg/dL or greater with respect
to the preoperative level.
● Respiratory insufficiency: PaO2 of less than 60 mm Hg
in current air.
● Intraoperative stroke: New focal neurologic deficit or
coma associated with computed tomographic demon-
stration of recent ischemic cerebral lesion that became
evident at the moment of the awakening of the patient
from anesthesia and lasted for more than 24 hours.
● Postoperative stroke: New focal neurologic deficit or
coma associated with computed tomographic demon-
stration of recent ischemic cerebral lesion and lasting
for more than 24 hours that became evident after a
normal awakening of the patient from anesthesia and a
normal postoperative neurologic status.
● Minor postoperative complications: Renal insuffi-
ciency, mechanical ventilation for more than 24 hours,
respiratory insufficiency, inotropic support for more
than 24 hours, need for blood transfusions, and revi-
sion for bleeding.
● Major postoperative complications: Death, stroke,
shock, sepsis, myocardial infarction, and reoperation.
● Hemorrhagic postoperative complications: Need for
blood transfusions and revision for bleeding.
Routine Blood Assay Methods
Platelet, WBC, neutrophil, lymphocyte, and monocyte
counts were measured automatically (Technnicon H3 RTX,
Bayer, Germany). Measurements of prothrombin time (ex-
pressed as INR) and activated PTT were also carried out
automatically (Elektra 1800, MLA).
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